{"id":"W2009085459","doi":"10.1517/13543780903336050","title":"Antivascular agents for non-small-cell lung cancer: current status and future directions","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bevacizumab; Medicine; Oncology; Targeted therapy; Lung cancer; Clinical trial; Internal medicine; Vascular endothelial growth factor; Chemotherapy; Monoclonal antibody; Cancer; Intensive care medicine; VEGF receptors; Immunology; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009918191,0.0007543712,0.001557305,0.001194534,0.0002494396,0.0009240937,0.001007473,0.001322204,0.003758344],"category_scores_gemma":[0.0007347937,0.000224362,0.0005257758,0.00143126,0.0004731815,0.001627619,0.000451429,0.001796633,0.002285314],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006208547,"about_ca_system_score_gemma":0.001149594,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007965481,"about_ca_topic_score_gemma":0.001931633,"domain_scores_codex":[0.9998052,0.00003922996,0.00002780497,0.00002873751,0.00007871012,0.00002051964],"domain_scores_gemma":[0.9995375,0.0002170644,0.00006451332,0.000009977739,0.0001227724,0.00004830939],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001457887,0.0001077287,0.0001396592,0.01048518,0.00006462858,0.0002130612,0.0000302822,0.0003126171,0.001795681,0.001611206,0.03218909,0.9529051],"study_design_scores_gemma":[0.0001167799,0.0003187447,0.000901981,0.004081968,0.000190286,0.001954804,0.00007618486,0.0002367792,0.0007424661,0.00228253,0.9890726,0.0000248878],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000982317,0.9987099,0.000094767,0.0004543492,0.0001973192,0.000004712191,0.000008020829,0.000006329864,0.0004264082],"genre_scores_gemma":[0.000427981,0.9986224,0.000175329,0.0002213988,0.0002139609,0.000006020923,0.00001546309,9.659622e-7,0.0003163875],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003758344,"threshold_uncertainty_score":0.01257288,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03724310527637133,"score_gpt":0.3574895587803171,"score_spread":0.3202464535039458,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}